Karin Wehlin
Chief Executive Officer bei DIAGONAL BIO AB
Profil
Karin Wehlin is the founder of EQL Pharma AB, which was founded in 2006.
She is currently the Chief Executive Officer at Diagonal Bio AB since 2024.
Previously, she held the position of Chief Executive Officer at LU Food Science AB, BoMill AB, and Respiratorius AB.
Ms. Wehlin obtained an MBA from the University of Lund.
Aktive Positionen von Karin Wehlin
| Unternehmen | Position | Beginn |
|---|---|---|
| DIAGONAL BIO AB | Chief Executive Officer | 28.02.2024 |
Ehemalige bekannte Positionen von Karin Wehlin
| Unternehmen | Position | Ende |
|---|---|---|
| BOMILL AB | Chief Executive Officer | - |
Respiratorius AB
 Respiratorius AB Pharmaceuticals: MajorHealth Technology Respiratorius AB engages in the development of drug candidates for Chronic Obstructive Pulmonary Disease, asthma, and cancer. The company was founded by Lars Christer Fedrik Fåhraeus and Staffan Skogwall in 1999 and is headquartered in Lund, Sweden. | Chief Executive Officer | - |
| LU Food Science AB | Chief Executive Officer | - |
| EQL PHARMA AB | Founder | - |
Ausbildung von Karin Wehlin
| University of Lund | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 4 |
|---|---|
| EQL PHARMA AB | Health Technology |
 | Health Technology |
| BOMILL AB | Technology Services |
| DIAGONAL BIO AB | Health Technology |
| Private Unternehmen | 1 |
|---|---|
| LU Food Science AB |
